132 related articles for article (PubMed ID: 23613993)
1. Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae.
Aravindan S; Delma CR; Thirugnanasambandan SS; Herman TS; Aravindan N
PLoS One; 2013; 8(4):e61977. PubMed ID: 23613993
[TBL] [Abstract][Full Text] [Related]
2. Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer.
Aravindan S; Ramraj SK; Somasundaram ST; Herman TS; Aravindan N
Stem Cell Res Ther; 2015 Sep; 6(1):182. PubMed ID: 26395574
[TBL] [Abstract][Full Text] [Related]
3. Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells.
Aravindan S; Ramraj S; Kandasamy K; Thirugnanasambandan SS; Somasundaram DB; Herman TS; Aravindan N
Oncotarget; 2017 Jan; 8(4):5717-5734. PubMed ID: 27974694
[TBL] [Abstract][Full Text] [Related]
4. Novel adjuvants from seaweed impede autophagy signaling in therapy-resistant residual pancreatic cancer.
Aravindan S; Ramraj SK; Somasundaram ST; Aravindan N
J Biomed Sci; 2015 Apr; 22(1):28. PubMed ID: 25898131
[TBL] [Abstract][Full Text] [Related]
5. Fucoidan from marine brown algae attenuates pancreatic cancer progression by regulating p53 - NFκB crosstalk.
Delma CR; Thirugnanasambandan S; Srinivasan GP; Raviprakash N; Manna SK; Natarajan M; Aravindan N
Phytochemistry; 2019 Nov; 167():112078. PubMed ID: 31450091
[TBL] [Abstract][Full Text] [Related]
6. Fucoidan from Turbinaria conoides: a multifaceted 'deliverable' to combat pancreatic cancer progression.
Delma CR; Somasundaram ST; Srinivasan GP; Khursheed M; Bashyam MD; Aravindan N
Int J Biol Macromol; 2015 Mar; 74():447-57. PubMed ID: 25541359
[TBL] [Abstract][Full Text] [Related]
7. Marine bioactive compound dieckol induces apoptosis and inhibits the growth of human pancreatic cancer cells PANC-1.
Xu JW; Yan Y; Wang L; Wu D; Ye NK; Chen SH; Li F
J Biochem Mol Toxicol; 2021 Feb; 35(2):e22648. PubMed ID: 33051972
[TBL] [Abstract][Full Text] [Related]
8. Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols.
Aravindan S; Somasundaram DB; Somasundaram ST; Natarajan M; Herman TS; Aravindan N
Mol Cell Biochem; 2019 Oct; 460(1-2):175-193. PubMed ID: 31367889
[TBL] [Abstract][Full Text] [Related]
9. Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway.
Zheng YT; Yang HY; Li T; Zhao B; Shao TF; Xiang XQ; Cai WM
Acta Pharmacol Sin; 2015 May; 36(5):614-26. PubMed ID: 25864651
[TBL] [Abstract][Full Text] [Related]
10. Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.
Siddique HR; Liao DJ; Mishra SK; Schuster T; Wang L; Matter B; Campbell PM; Villalta P; Nanda S; Deng Y; Saleem M
Int J Cancer; 2012 Oct; 131(7):1720-31. PubMed ID: 22190076
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.
El-Rayes BF; Ali S; Ali IF; Philip PA; Abbruzzese J; Sarkar FH
Cancer Res; 2006 Nov; 66(21):10553-9. PubMed ID: 17079479
[TBL] [Abstract][Full Text] [Related]
12. Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway.
Yang L; Lin S; Kang Y; Xiang Y; Xu L; Li J; Dai X; Liang G; Huang X; Zhao C
J Exp Clin Cancer Res; 2019 Jan; 38(1):31. PubMed ID: 30674340
[TBL] [Abstract][Full Text] [Related]
13. Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling.
Chen L; Feng D; Qian Y; Cheng X; Song H; Qian Y; Zhang X; Wu Y; Lv H; Liu Q; Cheng G; Yang B; Gu M
Phytomedicine; 2021 May; 85():153537. PubMed ID: 33744595
[TBL] [Abstract][Full Text] [Related]
14. Polyphenols from brown alga, Padina boergesenii (Allendar & Kraft) decelerates renal cancer growth involving cell cycle arrest and induction of apoptosis in renal carcinoma cells.
Rajamani K; Thirugnanasambandan SS
Environ Toxicol; 2018 Nov; 33(11):1135-1142. PubMed ID: 30126067
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy.
Ali S; El-Rayes BF; Sarkar FH; Philip PA
Mol Cancer Ther; 2005 Dec; 4(12):1943-51. PubMed ID: 16373709
[TBL] [Abstract][Full Text] [Related]
16. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
17. The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells.
Guzmán EA; Maers K; Roberts J; Kemami-Wangun HV; Harmody D; Wright AE
Invest New Drugs; 2015 Feb; 33(1):86-94. PubMed ID: 25416019
[TBL] [Abstract][Full Text] [Related]
18. Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor.
Zhang Z; Guo Y; Chen M; Chen F; Liu B; Shen C
Inflammopharmacology; 2021 Oct; 29(5):1587-1601. PubMed ID: 34322786
[TBL] [Abstract][Full Text] [Related]
19. Spongiatriol inhibits nuclear factor kappa B activation and induces apoptosis in pancreatic cancer cells.
Guzmán E; Maher M; Temkin A; Pitts T; Wright A
Mar Drugs; 2013 Apr; 11(4):1140-51. PubMed ID: 23549285
[TBL] [Abstract][Full Text] [Related]
20. New insights into seaweed polyphenols on glucose homeostasis.
Murugan AC; Karim MR; Yusoff MB; Tan SH; Asras MF; Rashid SS
Pharm Biol; 2015 Aug; 53(8):1087-97. PubMed ID: 25630358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
